VistA-internationalization/TranslationSpreadsheets/WV-DIALOG-0217.txt

308 lines
7.2 KiB
Plaintext
Raw Permalink Normal View History

2009-11-15 23:33:32 -05:00
English French Notes Complete/Exclude
BURNING ON URINATION:
LOW RED BLOOD COUNT:
KIDNEY PROBLEMS:
Females Only:
PREGNANT:
Males Only:
DISCHARGE FROM PENIS:
IMPOTENCE:
OTHER:
RASH/ULCERS ON PENIS:
PATIENT LABORATORY INFORMATION
Aldolase
Anti-DNA Antibody
Anti-skeletal muscle
Alkaline phosphatase
Anti-RNP
Urea nitrogen
Hepatitis B Antibody
Hepatitis B Antigen
Cholesterol
Complement CH50
Cryoglobulins
Creatinine
Complement
Glucose
Complement C4
HLA B27
Bilirubin, total
Latex fixation
Protein, total
Uric acid
Salicylate
UR Glucose
UR Protein
RBC/HPF
WBC/HPF
Granular/cast/lpf
Choloride
WBC/CASTS/LPF
Bicarbonate
Creatinine Clearance
Neutrophil
Bands
Lymphs
Monocytes
Eosino
Baso
Platelet
Reticulocytes
Westergren ESR
Protrhombin time
Partial thromboplastin
NARRATIVE HISTORY
Physical Examination
General:
LYMPH NODE ENLARGEMENT:
UVEITIS/IRITIS:
MUSCLE TENDERNESS:
CONJUNCTIVITIS/EPISCLERITIS:
MUSCLE WEAKNESS-DISTAL:
CATARACT:
MUSCLE WEAKNESS-PROXIMAL:
ORAL ULCERS:
MUSCLE ATROPHY
RALES:
PSYCHOSIS:
PLEURAL RUB/
CLINICAL PLEURISY:
ORGANIC BRAIN SYNDROME:
PLEURAL EFFUSION:
MOTOR NEUROPATHY:
PERICARDIAL RUB/PERICARDITIS:
SENSORY NEUROPATHY:
CUTANEOUS VASCULTITIS:
RASH-MALAR:
PALPABLE PUPURA:
RASH-DISCOID:
SKIN ULCERS:
RASH-JRA:
ERYTHEMA NODOSUM:
RASH-SLE,NON-MALAR:
PERIUNGAL ERYTHEMA:
RASH-OTHER:
HELIOTROPE EYELIDS:
KNUCKLE ERYTHEMA:
TELANGIECTASIS:
SUBCUTANEOUS CALCIFICATIONS:
SCLERODACTYLY:
KERATODERMIA BLENNORRHAGICA:
SCLERODERMA-EXTREMITY:
DACTYLITIS:
SCLERODERMA-GENERALIZED:
NAIL PITTING:
MORPHEA:
PSORIASIS:
DIGITAL ULCERS:
HEEL PAIN:
HEALTH ASSESSMENT
Questionnaire date:
Study status:
Drug Study:
Dressing and Grooming:
Arising:
Eating:
Walking:
Hygiene:
Reach:
Activities:
Pain Scale:
II. CLINICAL DATA
Sex
Age
NYHA functional class
Creatinine
III. CARDIAC CATHETERIZATION AND ANGIOGRAPHIC DATA
LVEDP
Lv Contraction Score (from contrast or
Aortic systolic pressure
radionuclide angiogram or 2D echo)
*PA systolic pressure
*PAW mean pressure
Grade Ejection Fraction Definition
*patients having right heart cath.
Range
Percent left main stenosis
Number of other major coronary
arteries (LAD,right with PDA,
circumflex with marginals)
with stenosis(es) => 50%
IV. OPERATIVE RISK SUMMARY DATA
Physician's preoperative
estimate of operative
V. OPERATIVE DATA
CABG distal anastomoses:
number with vein
number with IMA
Great vessel repair requiring
Other(not checked above)
Date of death
Renal failure requiring
Repeat cardiopulmonary
Repeat Cardiopulmonary
TIME TEST:
AGE:
WT LBS:
REF PHYS:
ETT PROTOCOL:
HYPERVENTILATION:
TARGET HR:
RESTING EKG:
ONSET CP
PEAK EX
SBP/DBP
ST/SLP
RPP/1000
MIN:SEC
PEAK MPH:
% TARGET HR:
TIME ST SEGMENT RETURN TO BASELINE:
SIGNIFICANT ARRHYTHMIAS:
BLOOD PRESSURE CHANGES:
OTHER EKG CHANGES:
COMPLICATIONS:
EKG TECH:
ATTN PHYS:
-------------------------------VENTRICULAR STUDY----------------------------
PREMEDICATION:
RECORDING SITE SITE:
VENTRICULAR THRESHOLD (mA):
REPETITIVE RESPONSES
VENT. EFF. REFR. PERIOD
BURST PACING (# REP. RESPONSES):
SHORTEST BURST CL:
INITIATION SEQUENCE OF V-T:
DURATION OF V-T/V-F:
V-T CYCLE LENGTH:
AXIS:
TERMINATION OF VT:
PACE OUT CYCLE LENGTH OF V-T:
CARDIOVERSION (J):
RHYTHM:
MEDICATIONS ON DISCHARGE:
CATHETERIZATION REPORT
ECHO REPORT
ECG REPORT
EP REPORT
HOLTER REPORT
RHEUMATOLOGY REPORT
ETT REPORT
Enter patient name or the date & time:
Pg.
CONFIDENTIAL
PROCEDURE DATE/TIME:
Select Patient Name or Date of Procedure to Delete:
ARE YOU SURE YOU WANT TO DELETE
Procedure Deleted
A-LEAD REPORT
V-LEAD REPORT
GENERATOR IMPLANT REPORT
PACEMAKER SURVEILLANCE REPORT
COMBINED IMPLANT/LEADS PROCEDURES
Enter Patient name or Date of Generator Implant:
Generator Information....
Atrial Lead Data....
Ventricular Lead Data...
GENERATOR DATA...
Ventricular
Atrial
Lead data entered for this patient
Lead implanted on
DEMOGRAPHIC INFORMATION
ACTIVE PATIENT LIST
This report has been set up to print with a line length of 132
characters. Select a device that uses a 132 character line length.
<RETURN> to continue
PACEMAKER ACTIVE PATIENT LIST
<RETURN> to Continue
EAST PSC FOLLOW-UP
REGISTRY ONLY
WEST PSC FOLLOW-UP
Pg.
GENERATOR IMPLANT DATA
V AND A LEAD IMPLANT DATA
MFR MODEL
SER. NO.
Enter Patient Name, or Date and Time:
SURVEILLANCE PROCEDURES
*** SCREEN EDIT ***
*** BRIEF EDIT ***
MCAR(698
TYPE OF LEAD NOT DEFINED FOR THIS PATIENT IN GENERATOR FILE
PRESS RETURN TO CONTINUE:
PACEMAKER SURVEILLANCE
PATIENT HAS NO CURRENT GENERATOR IMPLANT LISTED IN GENERATOR FILE
Entry Deleted
FORM TRANSFER TO NATIONAL CENTER
Select Reason for Transmission of this Report:
Transfer Report to :
WESTERN PACEMAKER CENTER
EASTERN PACEMAKER CENTER
Answer with 'E' for Eastern Center,'W' for Western Center, or 'B' for Both
BOTH EASTERN AND WESTERN PACEMAKER CENTERS
TRANSMIT REPORT
MCR(
PACEMAKER REPORT TRANSMISSION
PACEMAKER CENTER REPORT
REGISTRATION FORM DATA
REASON(S) FOR REPORT:
TELEPHONE FOLLOW-UP PROVIDED BY:
EASTERN PACEMAKER SURVEILLANCE CENTER
WESTERN PACEMAKER SURVEILLANCE CENTER
LOCAL VAMC
PULSE GENERATOR
MFR:
BEGINNING OF LIFE MAGNET RATE:
END OF LIFE MAGNET RATE:
TELEPHONES:
IMPLANTING HOSPITAL:
HOME:
WORK:
DATE OF INITIAL IMPLANT:
RESPONSIBLE PHYSICIAN:
MCPHYS(
PULSE GENERATORS INCLUDING PRESENT:
ATRIAL LEAD
VENTRICULAR LEAD
ATRIAL LEAD
MODEL #:
SERIAL #:
DATE:
PART 2
ALTERNATE CONTACT
ALTERNATE CONTACT ADDRESS
TELEPHONE TRANSMITTER:
MODEL #:
IMPLANT PARAMETERS: ATRIAL LEAD
THRESHOLD IN VOLTS
THRESHOLD IN MAs
AT .5 MS PW
RESISTANCE AT 5 VOLTS
R-WAVE OR P-WAVE
PSA USED:
SURVEILLANCE DATA
PROGRAMMED SETTINGS
PULSE WIDTH
AMPLITUDE
SENSITIVITY
REFRACTORY PERIOD
LOWER RATE LIMIT:
UPPER RATE LIMIT:
PACING MODE:
CLINIC MEASUREMENTS
PULSE WIDTH
AMPLITUDE
RATIO (T/L)
THRESHOLD WIDTH
THRESHOLD AMPLITUDE
CAPTURE
SENSE
RATE NO MAGNET:
RATE MAGNET:
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################